Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2011 by Shenzhen Kangzhe Pharmaceutical Co., Ltd..
Recruitment status was:  Enrolling by invitation
Fudan University
Medpace, Inc.
Information provided by (Responsible Party):
Shenzhen Kangzhe Pharmaceutical Co., Ltd. Identifier:
First received: December 1, 2011
Last updated: December 13, 2011
Last verified: December 2011
No Study Results Posted on for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: August 2013
  Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)